Shares of Health Care sector company Amgen moved -0.6% today, and are now trading at a price of $271.19. The large-cap stock's daily volume was 813,981 compared to its average volume of 2,490,976. The S&P 500 index returned a 0.0% performance.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company is based in Thousand Oaks and has 25,200 full time employees. Its market capitalization is $145,132,240,896. Amgen currently offers its equity investors a dividend that yields 3.1% per year.
22 analysts are following Amgen and have set target prices ranging from $174.47 to $301.79 per share. On average, they have given the company a rating of buy. At today's prices, AMGN is trading 4.79% away from its average analyst target price of $258.8 per share.
Over the last year, AMGN shares have gone down by -6.0%, which represents a difference of -21.0% when compared to the S&P 500. The stock's 52 week high is $296.67 per share and its 52 week low is $211.71. Although Amgen's average free cash flow over the last 6 years has been $9.3 Billion, they have been decreasing at an average rate of -1.4%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 10,800,000 | 1,115,000 | 9,685,000 | 10.24 |
| 2022 | 9,721,000 | 936,000 | 8,785,000 | 4.82 |
| 2021 | 9,261,000 | 880,000 | 8,381,000 | -15.25 |
| 2020 | 10,497,000 | 608,000 | 9,889,000 | 15.9 |
| 2019 | 9,150,000 | 618,000 | 8,532,000 | -19.19 |
| 2018 | 11,296,000 | 738,000 | 10,558,000 |
